RE:1-2 punchHey BinTraden, You missed something that is hanging over the stock in a BIG way. The Bondholders have retained Legal Counsel and the company is now (according to the CFO) focused on their "viability" (Quote from Q3 conference call). YIKES! But glad that you think the shares are cheap - as the Chairman of the Board has blew out of 90% of his shares. And there are some other troublesome rumblings which I won't get into here.
BinTraden wrote: Today is a combination of VRX getting a big downgrade, charges being laid reminding everyone about the cloud that hangs over these two stocks. IBB still in pullback mode doesn't help either.
Valeant Pharma (NYSE:VRX) Downgrade
Mizuho has cut Valeant Pharma (NYSE:VRX) stock to Underperform in an analyst note sent to investors and clients on Wednesday morning, and has set a 12 month PT at $11. VRX’s old rating was Neutral.
I just picked up some shares at $3.40 CAD > bargain!